These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7508628)

  • 1. Artificial protein vaccines with predetermined tertiary structure: application to anti-HIV-1 vaccine design.
    Eroshkin AM; Zhilkin PA; Shamin VV; Korolev S; Fedorov BB
    Protein Eng; 1993 Nov; 6(8):997-1001. PubMed ID: 7508628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design of four-helix protein--a possible vaccine against human immunodeficiency virus (HIV-1)].
    Eroshkin AM; Zhilkin PA; Shamin VV
    Mol Biol (Mosk); 1993; 27(3):538-51. PubMed ID: 7686249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of four-helix bundle protein as a candidate for HIV vaccine.
    Eroshkin AM; Karginova EA; Gileva IP; Lomakin AS; Lebedev LR; Kamyinina TP; Pereboev AV; Ignat'ev GM
    Protein Eng; 1995 Feb; 8(2):167-73. PubMed ID: 7543204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB; Ilyichev AA; Eroshkin AM; Karpenko LI; Pokrovsky AG; Pereboev AV; Svyatchenko VA; Ignat'ev GM; Smolina MI; Melamed NV; Lebedeva CD; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):129-37. PubMed ID: 8717396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and construction of a recombinant epitope-peptide gene as a universal epitope-vaccine strategy.
    Liu Z; Chen YH
    J Immunol Methods; 2004 Feb; 285(1):93-7. PubMed ID: 14871538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
    Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
    Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
    McGettigan JP; Koser ML; McKenna PM; Smith ME; Marvin JM; Eisenlohr LC; Dietzschold B; Schnell MJ
    Virology; 2006 Jan; 344(2):363-77. PubMed ID: 16226782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
    Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S
    AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses.
    Finnefrock AC; Liu X; Opalka DW; Shiver JW; Casimiro DR; Condra JH
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1283-92. PubMed ID: 17961117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125.
    Campbell AP; Sykes BD; Norrby E; Assa-Munt N; Dyson HJ
    Fold Des; 1996; 1(2):157-65. PubMed ID: 9079375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular construction of experimental combined vaccines].
    Lebedev LR; Sizov AA; Karpenko LI; Poryvaeva VA; Odegov AM
    Mol Gen Mikrobiol Virusol; 2002; (1):17-21. PubMed ID: 11904919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen synthesis opens the door to a broad-spectrum AIDS vaccine.
    Creavin T
    Drug Discov Today; 2004 Jun; 9(12):507-8. PubMed ID: 15183153
    [No Abstract]   [Full Text] [Related]  

  • 18. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
    Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
    J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.